Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) infection has emerged in patients who do not have the established risk factors. The national burden and clinical effect of this novel presentation of MRSA disease are unclear. METHODS: We evaluated MRSA infections in patients identified from population-based surveillance in Baltimore and Atlanta and from hospital-laboratory-based sentinel surveillance of 12 hospitals in Minnesota. Information was obtained by interviewing patients and by reviewing their medical records. Infections were classified as community-associated [correction] MRSA disease if no established risk factors were identified. RESULTS: From 2001 through 2002, 1647 cases of community-associated [correction] MRSA infection were reported, representing between 8 and 20 percent of all MRSA isolates. The annual disease incidence varied according to site (25.7 cases per 100,000 population in Atlanta vs. 18.0 per 100,000 in Baltimore) and was significantly higher among persons less than two years old than among those who were two years of age or older (relative risk, 1.51; 95 percent confidence interval, 1.19 to 1.92) and among blacks than among whites in Atlanta (age-adjusted relative risk, 2.74; 95 percent confidence interval, 2.44 to 3.07). Six percent of cases were invasive, and 77 percent involved skin and soft tissue. The infecting strain of MRSA was often (73 percent) resistant to prescribed antimicrobial agents. Among patients with skin or soft-tissue infections, therapy to which the infecting strain was resistant did not appear to be associated with adverse patient-reported outcomes. Overall, 23 percent of patients were hospitalized for the MRSA infection. CONCLUSIONS: Community-associated MRSA infections are now a common and serious problem. These infections usually involve the skin, especially among children, and hospitalization is common.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current epidemic of CA-MRSA in the United States and elsewhere disproportionally affects individuals of African descent with severe and invasive infections (Fridkin et al., 2005).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Fridkin et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362
Methicillin-Resistant Staphylococcus aureus
Brumfitt, W., & Hamilton-Miller, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201806 · Cited by 934
Staphylococcus aureus: A Well–Armed Pathogen
Archer, G. L. (1998) · Clinical Infectious Diseases · doi:10.1086/520289 · Cited by 658
Lorenz, E., Mira, J. P., Cornish, K. L., Arbour, N. C., & Schwartz, D. A. (2000) · Infection and Immunity · doi:10.1128/.68.11.6398-6401.2000 · Cited by 598
Research works printed but not linked: 5
- Methicillin-resistant Staphylococcus aureus infections in correctional facilities -Geor- gia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 2003;52: 992-6.
- Methicillin-resistant Staphylococcus aureus infections among competitive sports par- ticipants -Colorado, Indiana, Pennsylva- nia, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003;52: 793-5.
- Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections -Los Angeles County, Califor- nia, 2002-2003. MMWR Morb Mortal Wkly Rep 2003;52:88.
- Community-associated methicillin- resistant Staphylococcus aureus infections in Pacific Islanders -Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep 2004;53: 767-70.
- Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison -Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001;50:919-22.
Cited by
Items 201–300 of 1,000
Fritz, S. A., Garbutt, J., Elward, A., Shannon, W., & Storch, G. A. (2008) · Pediatrics · doi:10.1542/peds.2007-2104 · Cited by 99
Yao, J., Zhong, J., Fang, Y., Geisinger, E., Novick, R. P., & Lambowitz, A. M. (2006) · RNA · doi:10.1261/rna.68706 · Cited by 100
van Hal, S. J., Stark, D. J., Lockwood, B. M., Marriott, D. J. E., & Harkness, J. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00139-07 · Cited by 98
Tong, S. Y. C., Chen, L. F., & Fowler, V. G. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0300-x · Cited by 127
The role of Staphylococcus aureus quorum sensing in cutaneous and systemic infections
Yamazaki, Y., Ito, T., Tamai, M., Nakagawa, S., & Nakamura, Y. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00323-8 · Cited by 112
Evolving problems with resistant pathogens
Chastre, J. E. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01958.x · Cited by 113
Mera, R. M., Suaya, J. A., Amrine‐Madsen, H., Hogea, C. S., Miller, L. A., Lu, E., Sahm, D. F., O’Hara, P. J., & Acosta, C. J. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2010.0193 · Cited by 114
Mohammad, H., Reddy, P. V., Monteleone, D., Mayhoub, A. S., Cushman, M., & Seleem, M. N. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.015 · Cited by 105
Tigecycline: a novel glycylcycline antibiotic
Zhanel, G. G., Karlowsky, J. A., Rubinstein, E., & Hoban, D. J. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.1.9 · Cited by 102
Speziali, C. D., Dale, S. E., Henderson, J. A., Vinés, E. D., & Heinrichs, D. E. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.6.2048-2055.2006 · Cited by 95
Barton, M., Hawkes, M., MOORE, D. L., Conly, J. M., Nicolle, L. E., Allen, U., Boyd, N., Embreé, J., Horne, L. V., Saux, N. L., et al. (2006) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2006/971352 · Cited by 103
Barefoot Running Claims and Controversies
Jenkins, D. W., & Cauthon, D. J. (2011) · Journal of the American Podiatric Medical Association · doi:10.7547/1010231 · Cited by 94
Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus
Kaka, A. S., Rueda, A. M., Shelburne, S. A., Hultén, K. G., Hamill, R. J., & Musher, D. M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl283 · Cited by 94
Fritz, S. A., Epplin, E. K., Garbutt, J., & Storch, G. A. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.09.001 · Cited by 95
Mucroporin, the First Cationic Host Defense Peptide from the Venom ofLychas mucronatus
Chao, D., Ma, Y., Zhao, Z., Zhao, R., Wang, Q., Wu, Y., Cao, Z., & Li, W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00542-08 · Cited by 109
David, M. Z., Daum, R. S., Bayer, A. S., Chambers, H. F. “., Fowler, V. G., Miller, L. G., Ostrowsky, B. E., Baesa, A., Boyle‐Vavra, S., Eells, S. J., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu410 · Cited by 101
Popovich, K. J., Hota, B. N., Aroutcheva, A. A., Kurien, L., Patel, J. B., Lyles-Banks, R. D., Grasso, A. E., Spec, A., Beavis, K. G., Hayden, M. K., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit010 · Cited by 102
Rutar, T., Chambers, H. F. “., Crawford, J. B., Perdreau‐Remington, F., Zwick, O. M., Karr, M., Diehn, J. J., & Cockerham, K. P. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.03.031 · Cited by 93
Biopolymer K-carrageenan wrapped ZnO nanoparticles as drug delivery vehicles for anti MRSA therapy
Vijayakumar, S., Saravanakumar, K., Malaikozhundan, B., Divya, M., Vaseeharan, B., Durán‐Lara, E. F., & Wang, M. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.12.030 · Cited by 91
Lautenbach, E., Nachamkin, I., Hu, B., Fishman, N. O., Tolomeo, P., Prasad, P. A., Bilker, W. B., & Zaoutis, T. E. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/596045 · Cited by 101
Role of Bacterial Superantigens in Atopic Dermatitis: Implications for Future Therapeutic Strategies
Cardona, I. D., Cho, S. H., & Leung, D. Y. M. (2006) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200607050-00001 · Cited by 104
Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
Projan, S., Nesin, M., & Dunman, P. M. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.005 · Cited by 88
Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in Children
Kaplan, S. L. (2006) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2006.06.004 · Cited by 97
Milstone, A. M., Goldner, B. W., Ross, T., Shepard, J. W., Carroll, K. C., & Perl, T. M. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir547 · Cited by 89
Drago, L., Vecchi, E. D., Nicola, L., & Gismondo, M. R. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-111 · Cited by 103
Cohen, P. R. (2007) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2007.03215.x · Cited by 97
Burden of Methicillin‐Resistant Staphylococcus aureus: Focus on Clinical and Economic Outcomes
Lodise, T. P., & McKinnon, P. S. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.7.1001 · Cited by 106
Simor, A. E., Gilbert, N. L., Gravel, D., Mulvey, M. R., Bryce, E., Loeb, M., Matlow, A., McGeer, A., Louie, L., Campbell, J., et al. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651313 · Cited by 87
“1,917 (45) 690 (16) 582 (14) 1,096 (26)”
InfluentialLinezolid-induced optic neuropathy: a mitochondrial disorder?
Javaheri, M., Khurana, R. N., O’Hearn, T. M., Lai, M. M.-S., & Sadun, A. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.102541 · Cited by 88
Frazee, B. W., Salz, T. O., Lambert, L., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2005.05.023 · Cited by 86
O’Riordan, W. D., Tiffany, C. A., Scangarella-Oman, N. E., Perry, C., Hossain, M. S., Ashton, T., & Dumont, E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02095-16 · Cited by 85
Mechanisms of Pyocyanin Toxicity and Genetic Determinants of Resistance in Staphylococcus aureus
Noto, M. J., Burns, W. J., Beavers, W. N., & Skaar, E. P. (2017) · Journal of Bacteriology · doi:10.1128/jb.00221-17 · Cited by 125
Ardura, M. I., Banchereau, R., Mejias, A., Di Pucchio, T., Glaser, C., Allantaz, F., Pascual, V., Banchereau, J., Chaussabel, D., & Ramilo, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005446 · Cited by 85
Staphylococcus aureus in the Community: Colonization Versus Infection
Miller, M., Cook, H. A., Furuya, E. Y., Bhat, M., Lee, M., Vavagiakis, P., Visintainer, P., Vasquez, G., Larson, E., & Lowy, F. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006708 · Cited by 103
Prevention of surgical site infections
Hedrick, T. L., Anastacio, M. M., & Sawyer, R. G. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.2.223 · Cited by 93
Dandoy, C. E., Ardura, M. I., Papanicolaou, G. A., & Auletta, J. J. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.14 · Cited by 88
Stauff, D. L., Bagaley, D., Torres, V. J., Joyce, R., Anderson, K. L., Kuechenmeister, L., Dunman, P. M., & Skaar, E. P. (2008) · Journal of Bacteriology · doi:10.1128/jb.01921-07 · Cited by 83
Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?
Witte, W. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03097.x · Cited by 103
Acute bacterial skin infections and cellulitis
Gabillot-Carré, M., & Roujeau, J. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32805dfb2d · Cited by 87
Mouwakeh, A., Kincses, A., Nové, M., Mosolygó, T., Mohácsi‐Farkas, C., Kiskó, G., & Spengler, G. (2019) · Phytotherapy Research · doi:10.1002/ptr.6294 · Cited by 94
Paukner, S., Sader, H. S., Ivezic‐Schoenfeld, Z., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00358-13 · Cited by 84
How Common is MRSA in Adult Septic Arthritis?
Frazee, B. W., Fee, C. R., & Lambert, L. (2009) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2009.06.511 · Cited by 83
Microbial Telesensing: Probing the Environment for Friends, Foes, and Food
Roux, A., Payne, S. M., & Gilmore, M. S. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.07.004 · Cited by 90
Community-Associated Methicillin-Resistant Staphylococcus aureus
Wallin, T. R., Hern, H. G., & Frazee, B. W. (2008) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2008.01.010 · Cited by 98
Weber, D. J., & Rutala, W. A. (2006) · Infection Control & Hospital Epidemiology · doi:10.1086/507964 · Cited by 82
David, M. Z., Mennella, C., Mansour, M., Boyle‐Vavra, S., & Daum, R. S. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01423-08 · Cited by 88
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Pruett, T. L. (2006) · Yearbook of Surgery · doi:10.1016/s0090-3671(08)70392-6 · Cited by 82
Onanuga, A., & Awhowho, G. (2012) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.99058 · Cited by 94
Skov, R. L., Christiansen, K., Dancer, S. J., Daum, R. S., Dryden, M., Huang, Y., & Lowy, F. D. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.029 · Cited by 106
A veterinary perspective on methicillin-resistant staphylococci
Cohn, L. A., & Middleton, J. R. (2010) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2009.00497.x · Cited by 108
Miller, L. G., Eells, S. J., David, M. Z., Ortiz, N., Taylor, A. R., Kumar, N., Cruz, D., Boyle‐Vavra, S., & Daum, R. S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu943 · Cited by 85
Gabbay, V., Coffey, B. J., Babb, J. S., Meyer, L., Wachtel, C., Anam, S., & Rabinovitz, B. (2008) · Pediatrics · doi:10.1542/peds.2007-1307 · Cited by 81
Carroll, K. C., Borek, A. P., Burger, C., Glanz, B. D., Bhally, H. S., Henciak, S., & Flayhart, D. C. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02636-05 · Cited by 85
Methicillin-resistant Staphylococcus aureus: a new community-acquired pathogen?
Kollef, M. H., & Micek, S. T. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000216627.13445.e2 · Cited by 89
Case definition for community-associated methicillin-resistant Staphylococcus aureus
Morrison, M. A., Hageman, J. C., & Klevens, R. M. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.07.011 · Cited by 95
Self-citationAn update on community-associated MRSA virulence
Kobayashi, S. D., & DeLeo, F. R. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.07.009 · Cited by 92
Wang, W., Chiueh, T., Sun, J., Tsao, S.-M., & Lu, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030394 · Cited by 78
Shallcross, L. J., Williams, K., Hopkins, S., Aldridge, R. W., Johnson, A. M., & Hayward, A. C. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03153.x · Cited by 78
Wu, D., Li, X., Yang, Y., Zheng, Y., Wang, C., Deng, L., Liu, L., Li, C., Shang, Y., Zhao, C., et al. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.023465-0 · Cited by 78
Evasion of Neutrophil Killing by Staphylococcus aureus
McGuinness, W., Kobayashi, S. D., & DeLeo, F. R. (2016) · Pathogens · doi:10.3390/pathogens5010032 · Cited by 99
Schneider-Lindner, V., Delaney, J. A., Dial, S., Dascal, A., & Suissa, S. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1307.061561 · Cited by 78
Epidemiología e impacto de las infecciones nosocomiales
Olaechea, P., Ordeñana, J. I., Blanco, A., & Luque, P. (2010) · Medicina Intensiva · doi:10.1016/j.medin.2009.11.013 · Cited by 184
The Heme Sensor System of Staphylococcus aureus
Stauff, D. L., & Skaar, E. P. (2009) · Contributions to Microbiology · doi:10.1159/000219376 · Cited by 83
Sensitive and rapid amperometric magnetoimmunosensor for the determination of Staphylococcus aureus
de Ávila, B. E., Pedrero, M., Campuzano, S., Escamilla‐Gómez, V., & Pingarrón, J. M. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-5738-8 · Cited by 76
Mouse Model of Staphylococcus aureus Skin Infection
Małachowa, N., Kobayashi, S. D., Braughton, K. R., & DeLeo, F. R. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-481-4_14 · Cited by 88
Hamilton, S. M., Bryant, A. E., Carroll, K. C., Lockary, V. M., Ma, Y., McIndoo, E. R., Miller, L. G., Perdreau‐Remington, F., Pullman, J. R., Risi, G. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/523581 · Cited by 83
Ross, J. J. (2005) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2005.07.004 · Cited by 95
Community-associated Methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003
Buck, J. M., Como-Sabetti, K., Harriman, K. H., Danila, R. N., Boxrud, D. J., Glennen, A., & Lynfield, R. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1110.050141 · Cited by 76
Self-citationCarroll, R. K., Shelburne, S. A., Olsen, R. J., Suber, B., Sahasrabhojane, P. V., Kumaraswami, M., Beres, S. B., Shea, P. R., Flores, A. R., & Musser, J. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45169 · Cited by 82
Cellulitis: Definition, Etiology, and Clinical Features
Gunderson, C. G. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.06.028 · Cited by 77
Strausbaugh, L. J., Siegel, J. D., Weinstein, R. A., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500408 · Cited by 75
Munckhof, W., Nimmo, G. R., Carney, J., Schooneveldt, J. M., Huygens, F., Inman-Bamber, J., Tong, E. N. C., Morton, A., & Giffard, P. M. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0449-3 · Cited by 82
Schreiner, J., Kretschmer, D., Klenk, J., Otto, M. J., Bühring, H., Stevanović, S., Wang, J., Beer‐Hammer, S., Peschel, A., & Autenrieth, S. E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202563 · Cited by 85
Moellering, R. C., Graybill, J. R., McGowan, J. E., & Corey, L. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.04.001 · Cited by 84
Optimising Antimicrobial Therapy in Diabetic Foot Infections
Rao, N., & Lipsky, B. A. (2007) · Drugs · doi:10.2165/00003495-200767020-00003 · Cited by 73
Seybold, U., Halvosa, J. S., White, N., Voris, V., Ray, S. M., & Blumberg, H. M. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3161 · Cited by 80
Alekshun, M. N., & Levy, S. B. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.040 · Cited by 87
See, I., Freifeld, A. G., & Magill, S. S. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw113 · Cited by 80
Shorr, A. F., Micek, S. T., & Kollef, M. H. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818103ea · Cited by 79
Lodise, T. P., Pypstra, R., Kahn, J. B., Murthy, B. P., Kimko, H. C., Bush, K., Noel, G. J., & Drusano, G. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01181-06 · Cited by 75
Infection With Community-Onset Staphylococcus aureus and Influenza Virus in Hospitalized Children
Reed, C., Kallen, A. J., Patton, M., Arnold, K. E., Farley, M. M., Hageman, J., & Finelli, L. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819d8b71 · Cited by 72
Self-citationIs methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?
Mostofsky, E., Lipsitch, M., & Regev‐Yochay, G. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr278 · Cited by 82
Park, S. H., Park, C., Yoo, J., Choi, S., Choi, J., Shin, H.-H., Lee, D., Lee, S., Kim, J., Choi, S. E., et al. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/593953 · Cited by 75
National Athletic Trainers' Association Position Statement: Skin Diseases
Zinder, S. M., Basler, R. S. W., Foley, J., Scarlata, C., & Vasily, D. B. (2010) · Journal of Athletic Training · doi:10.4085/1062-6050-45.4.411 · Cited by 77
Gaspari, R., Resop, D. M., Mendoza, M., Kang, T. L., & Blehar, D. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.11.021 · Cited by 71
The changing face of community-acquired methicillin-resistant Staphylococcus aureus
Kale, P. R., & Dhawan, B. (2016) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.188313 · Cited by 79
Napolitano, L. M. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.04.006 · Cited by 78
Surveillance and management of multidrug-resistant microorganisms
Orsi, G. B., Falcone, M., & Venditti, M. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.77 · Cited by 80
Methicillin-Resistant Staphylococcus Aureus Infections
Taylor, A. R. (2013) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2013.06.002 · Cited by 83
Chen, W., Chang, W., Chen, Y.-S., Hsieh, K., Chen, C. K., Peng, N., Wu, K.-S., & Cheng, M. (2010) · Journal of Microbiology Immunology and Infection · doi:10.1016/s1684-1182(10)60051-5 · Cited by 68
Scharn, C. R., Tenover, F. C., & Goering, R. V. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01058-13 · Cited by 79
Kollef, M. H., Napolitano, L. M., Solomkin, J. S., Wunderink, R. G., Bae, I., Fowler, V. G., Balk, R. A., Stevens, D. L., Rahal, J. J., Shorr, A. F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590937 · Cited by 69
Williams, D. J., Cooper, W. O., Kaltenbach, L. A., Dudley, J. A., Kirschke, D., Jones, T. F., Arbogast, P. G., Griffin, M. R., & Creech, C. B. (2011) · PEDIATRICS · doi:10.1542/peds.2010-3681 · Cited by 71
Tedizolid (TR-701): a new oxazolidinone with enhanced potency
Kanafani, Z. A., & Corey, G. R. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.660250 · Cited by 73
Comparison of computerized tomography and ultrasound for diagnosing soft tissue abscesses
Gaspari, R., Dayno, M., Briones, J., & Blehar, D. (2012) · The Ultrasound Journal · doi:10.1186/2036-7902-4-5 · Cited by 68
Methicillin-resistant Staphylococcus aureus in orthopaedic surgery
Patel, A., Calfee, R. P., Plante, M., Fischer, S. A., Arcand, N., & Born, C. T. (2008) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.90b11.20771 · Cited by 78
Antimicrobial Peptides and Peptidomimetics - Potent Therapeutic Allies for Staphylococcal Infections
Mohammad, H. T., Thangamani, S., & Seleem, M. N. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150310102702 · Cited by 74
Jones, T. F., Creech, C. B., Erwin, P., Baird, S. G., Woron, A. M., & Schaffner, W. (2006) · Clinical Infectious Diseases · doi:10.1086/503265 · Cited by 67
Community associated methicillin-resistant Staphylococcus aureus.
Mertens, R., Seyler, L., Lacor, P., & Denis, O. (2012) · PubMed · doi:10.2143/acb.67.4.2062665 · Cited by 66
Tamarit, A. B., Cháves, F., Rojo, P., & Otero, J. R. (2006) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13083373 · Cited by 74
Metadata
- Authors
- Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Johns Hopkins University (US)
- Minnesota Department of Health (US)
- Emory University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-04-07
- Volume
- 352
- Issue
- 14
- Pages
- 1436-1444
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2114114837
- Cited by
- 1,493
- References
- 34
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 24 · 2023: 23 · 2022: 28 · 2021: 28 · 2020: 31 · 2019: 32 · 2018: 46 · 2017: 38 · 2016: 45 · 2015: 70 · 2014: 54 · 2013: 74 · 2012: 87
- FWCI
- 114.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Keywords
- methicillin-resistant Staphylococcus aureus, skin and soft tissue infections, antimicrobial resistance, hospitalization, sentinel surveillance, Baltimore, Atlanta, Minnesota
- MeSH terms
- Adolescent, Adult, Aged, Anti-Bacterial Agents, Black or African American, Child, Child, Preschool, Drainage, Georgia, Humans, Infant, Middle Aged, Minnesota, Population Surveillance, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Baltimore, Incidence, Methicillin Resistance, Community-Acquired Infections, Endemic Diseases, Black People, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.